130 related articles for article (PubMed ID: 9564184)
1. [Almitrine in therapy of chronic obstructive respiratory tract diseases with hypoxemia--a clinical multicenter study comparing 2 dosages].
Nowak D; Wywiol A; Magnussen H
Pneumologie; 1998 Mar; 52(3):121-7. PubMed ID: 9564184
[TBL] [Abstract][Full Text] [Related]
2. Sequential treatment with low dose almitrine bismesylate in hypoxaemic chronic obstructive airways disease.
Bardsley PA; Howard P; Tang O; Empey D; Harrison B; Peake MD; O'Reilly J; Riordan JF; Wilkinson J; Arnaud F
Eur Respir J; 1992 Oct; 5(9):1054-61. PubMed ID: 1426214
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of almitrine bismesylate in COPD patients with chronic hypoxaemia.
Sans-Torres J; Domingo C; Morón A; Rué M; Marín A
Respir Med; 2003 Jun; 97(6):599-605. PubMed ID: 12814142
[TBL] [Abstract][Full Text] [Related]
4. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
Voisin C; Howard P; Ansquer JC
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971
[TBL] [Abstract][Full Text] [Related]
5. Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease.
Bardsley PA; Howard P; DeBacker W; Vermeire P; Mairesse M; Ledent C; Radermecker M; Bury T; Ansquer J
Eur Respir J; 1991 Mar; 4(3):308-10. PubMed ID: 1907566
[TBL] [Abstract][Full Text] [Related]
6. Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease.
Winkelmann BR; Kullmer TH; Kneissl DG; Trenk D; Kronenberger H
Chest; 1994 May; 105(5):1383-91. PubMed ID: 8181324
[TBL] [Abstract][Full Text] [Related]
7. [Sequential administration of a reduced dose of almitrine to patients with chronic obstructive bronchopneumopathies. A controlled multicenter study].
Weitzenblum E; Arnaud F; Bignon J; Boutin C; Brune J; Castaing Y; Courty G; Derenne J; Duroux P; Fréour P
Rev Mal Respir; 1992; 9(4):455-63. PubMed ID: 1509190
[TBL] [Abstract][Full Text] [Related]
8. One year treatment with almitrine improves hypoxaemia but does not increase pulmonary artery pressure in COPD patients.
Weitzenblum E; Schrijen F; Apprill M; Prefaut C; Yernault JC
Eur Respir J; 1991 Nov; 4(10):1215-22. PubMed ID: 1804669
[TBL] [Abstract][Full Text] [Related]
9. Oral almitrine in treatment of acute respiratory failure and cor pulmonale in patients with an exacerbation of chronic obstructive airways disease.
Bardsley PA; Tweney J; Morgan N; Howard P
Thorax; 1991 Jul; 46(7):493-8. PubMed ID: 1908604
[TBL] [Abstract][Full Text] [Related]
10. Dose-response and pharmacokinetic study with almitrine bismesylate after single oral administrations in COPD patients.
Bury T; Jeannot JP; Ansquer JC; Radermecker M
Eur Respir J; 1989 Jan; 2(1):49-55. PubMed ID: 2495983
[TBL] [Abstract][Full Text] [Related]
11. [The first Italian clinical experience with almitrine bismesylate].
Grassi V; Bottino G; Blasi A; Grassi C
Rev Mal Respir; 1985; 2 Suppl 1():S53-60. PubMed ID: 2870548
[TBL] [Abstract][Full Text] [Related]
12. Effects of almitrine bismesylate on arterial blood gases in patients with chronic obstructive pulmonary disease and moderate hypoxaemia: a multicentre, randomised, double-blind, placebo-controlled study.
Górecka D; Sliwiński P; Pałasiewicz G; Pachocki R; Zieliński J;
Respiration; 2003; 70(3):275-83. PubMed ID: 12915747
[TBL] [Abstract][Full Text] [Related]
13. Almitrine fails to improve oxygenation during one-lung ventilation with sevoflurane anesthesia.
Bermejo S; Gallart L; Silva-Costa-Gomes T; Vallès J; Aguiló R; Puig MM
J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):919-24. PubMed ID: 24016684
[TBL] [Abstract][Full Text] [Related]
14. Association of oral almitrine and medroxyprogesterone acetate: effect on arterial blood gases in chronic obstructive pulmonary disease.
Pinet C; Tessonnier F; Ravel T; Orehek J
Respir Med; 2001 Jul; 95(7):602-5. PubMed ID: 11453318
[TBL] [Abstract][Full Text] [Related]
15. Almitrine effect on nocturnal hypoxaemia in patients with chronic obstructive pulmonary disease (COPD).
Daskalopoulou E; Patakas D; Tsara V; Kazis A; Maniki E; Zoglopitis F
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():185s-190s. PubMed ID: 3690030
[TBL] [Abstract][Full Text] [Related]
16. Effects of almitrine on the ventilatory control, breathing pattern and maximal exercise tolerance in hypoxemic patients with chronic obstructive pulmonary disease.
Ribeiro SA; Jardim JR; Romaldini H; Novo NF; Nery LE
Braz J Med Biol Res; 1995 Aug; 28(8):859-67. PubMed ID: 8555987
[TBL] [Abstract][Full Text] [Related]
17. Long-term effect of almitrine bismesylate in patients with hypoxemic chronic obstructive pulmonary disease.
Watanabe S; Kanner RE; Cutillo AG; Menlove RL; Bachand RT; Szalkowski MB; Renzetti AD
Am Rev Respir Dis; 1989 Nov; 140(5):1269-73. PubMed ID: 2683905
[TBL] [Abstract][Full Text] [Related]
18. [Almitrine bismesylate in chronic obstructive lung disease and persistent hypoxemia. Controlled double-blind study with oral administration].
Wuttke R; von Wichert P
Respiration; 1985; 48(4):285-95. PubMed ID: 3936140
[TBL] [Abstract][Full Text] [Related]
19. A review of clinical studies carried out in Italy with almitrine bismesylate.
Grassi V; Tantucci C; Sorbini CA; Grassi C; Cerveri I; Rampulla C; Bottino G; Giacometti A; Blasi A; Pezza A
Eur J Respir Dis Suppl; 1986; 146():671-6. PubMed ID: 3536560
[TBL] [Abstract][Full Text] [Related]
20. Vectarion International Multicentre Study (VIMS): a long term double blind placebo controlled trial in COLD patients.
Sadoul P
Eur J Respir Dis Suppl; 1983; 126():357-61. PubMed ID: 6373344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
